Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia.

about

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia

P2860

Q45811351-3013B58B-81F9-4235-B9E1-DC19133786C9 Q58696763-D32BDA8E-5750-48CC-BB20-EDBBCA90E436

P2860

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia.

Item

http://www.wikidata.org/entity/Q41683957

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cerebrospinal Fluid Biomarkers ...... Compared to Vascular Dementia.

@en

type

Item

label

Cerebrospinal Fluid Biomarkers ...... Compared to Vascular Dementia.

@en

prefLabel

Cerebrospinal Fluid Biomarkers ...... Compared to Vascular Dementia.

@en

P1476

Cerebrospinal Fluid Biomarkers ...... Compared to Vascular Dementia.

@en

P2093

Andre Fischer

http://www.w3.org/2001/XMLSchema#string

Christian Schmidt

http://www.w3.org/2001/XMLSchema#string

Franc Llorens

http://www.w3.org/2001/XMLSchema#string

Inga Zerr

http://www.w3.org/2001/XMLSchema#string

Matthias Schmitz

http://www.w3.org/2001/XMLSchema#string

Peter Hermann

http://www.w3.org/2001/XMLSchema#string

Peter Lange

http://www.w3.org/2001/XMLSchema#string

Tobias Knipper

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropathological alterations in Alzheimer disease

S100B in brain damage and neurodegeneration

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.

CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer's disease and multiple sclerosis

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease

P304

289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNAGI.2017.00289

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28955218

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

biomarker

P932

5601075

http://www.w3.org/2001/XMLSchema#string

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia.

about

P2860

P2860

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932